Valproic Acid–Induced Gene Expression through Production of Reactive Oxygen Species
Open Access
- 1 July 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (13), 6563-6569
- https://doi.org/10.1158/0008-5472.can-06-0814
Abstract
Valproic acid (VPA) is a widely used anticonvulsive agent that has profound antiproliferative effects in many cell types, as well as inductive effects on a number of genes. The mechanism of its gene-inducing effect has been reported to involve transcription factors, Sp1 and activator protein-1. Using two well-characterized antioxidant response element (ARE)–driven gene promoters, i.e., mouse heme oxygenase-1 and human NAD(P)H:quinone oxidoreductase 1 genes as tools to monitor the transcriptional response to VPA, we show here that VPA-induced gene transcription was abrogated by antioxidants. With the human Gαi2 gene promoter, which was previously used to establish the involvement of Sp1 in the transcriptional action of VPA, we found that VPA-induced gene transcription was also blocked by antioxidants. Mutation of the ARE (5′-TGACtggGC-3′) in this promoter abrogated the transcriptional response to VPA. With such mutants, the NADPH oxidase inhibitor, diphenyleneiodonium, had no effect on VPA-induced transcription. In gel mobility shift assays, VPA-induced binding of nuclear proteins to a DNA probe containing the relevant ARE sequence in the Gαi2 gene promoter was decreased in nuclear extracts from cells pretreated with antioxidants. Chromatin immunoprecipitation assays showed that the prototype redox-sensitive transcription factors, Nrf2, small Maf protein(s), and c-Fos, were recruited to this promoter in VPA-treated cells. Overall, this study reveals that the mechanism of the transcriptional response to VPA includes VPA-induced production of reactive oxygen species which induce the activation of redox-sensitive transcription factors that interact with the ARE. (Cancer Res 2006; 66(13): 6563-9)Keywords
This publication has 47 references indexed in Scilit:
- Induction of the Human Oxidized Base-specific DNA Glycosylase NEIL1 by Reactive Oxygen SpeciesPublished by Elsevier BV ,2005
- Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation ProteinsCancer Research, 2005
- Transcriptional Activation of the Human Gαi2 Gene Promoter through Nuclear Factor-κB and Antioxidant Response ElementsPublished by Elsevier BV ,2005
- Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular DifferentiationCancer Research, 2004
- Sp Family of Transcription Factors Is Involved in Valproic Acid-induced Expression of Gαi2Published by Elsevier BV ,2003
- Anticonvulsant valproic acid inhibits cardiomyocyte differentiation of embryonic stem cells by increasing intracellular levels of reactive oxygen speciesBirth Defects Research Part A: Clinical and Molecular Teratology, 2003
- Mechanism of Heme Oxygenase-1 Gene Activation by Cadmium in MCF-7 Mammary Epithelial CellsPublished by Elsevier BV ,2000
- Changes in Tyrosine Hydroxylase mRNA Expression in the Rat Locus Coeruleus Following Acute or Chronic Treatment with Valproic AcidNeuropsychopharmacology, 2000
- JunB Forms the Majority of the AP-1 Complex and Is a Target for Redox Regulation by Receptor Tyrosine Kinase and G Protein-coupled Receptor Agonists in Smooth Muscle CellsPublished by Elsevier BV ,1999
- Antitumor activity of sodium valproate in cultures of human neuroblastoma cellsAnti-Cancer Drugs, 1996